Staubach, P; Vonend, A; Burow, G et al.
Patients with chronic urticaria exhibit increased rates of sensitisation to Candida albicans, but not to common mouldsMYCOSES. Bd. 52. H. 4. 2009 S. 334-338
Schopf, R
Patients with moderate to severe plaque psoriasis show consistently a quick improvement of nail psoriasisJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 7. 2009 S. 193-193
Hauschild, A; Weichenthal, M; Rass, K et al.
Prospective randomized multicenter adjuvant dermatologic cooperative oncology group trial of low-dose interferon alfa-2b with or without a modified high-dose interferon alfa-2b induction phase in patients with lymph node-negative melanoma.J Clin Oncol. Bd. 27. H. 21. 2009 S. 3496-502
Becker, C; Taube, C; Bopp, T et al.
Protection from graft-versus-host disease by HIV-1 envelope protein gp120-mediated activation of human CD4(+)CD25(+) regulatory T cellsBLOOD. Bd. 114. H. 6. 2009 S. 1263-1269
Schopf, RE; Asefi, M
Psoriasis-arthritis: planning, constitutive and provocative factors in 50 patientsJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 7. 2009 S. 173-173
Schopf, RE; Palitzsch, A
Pustulosis palmaris et plantaris: Constitution, provocation and association factorsJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 7. 2009 S. 165-165
Bellinghausen, I; Luxemburger, U; Tuereci, O et al.
Recruitment of regulatory T cells by CCL18 which is induced in human CD4+T cells from allergic donors after stimulation with IL-10-treated dendritic cellsALLERGY. Bd. 64. 2009 S. 44-45
von Stebut, E
Recurring herpes infection - what to do for the vexationJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 7. 2009 S. 36-36
Hauschild, A; Agarwala, SS; Trefzer, U et al.
Results of a phase III, randomized, placebo-controlled study of sorafenib in combination with carboplatin and paclitaxel as second-line treatment in patients with unresectable stage III or stage IV melanoma.J Clin Oncol. Bd. 27. H. 17. 2009 S. 2823-30
Staubach, P; Bork, K
Safety Evaluation of Icatibant, a Selective Bradykinin B2 Receptor Antagonist Used in Hereditary Angioedema Due to C1 Inhibitor DeficiencyJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. Bd. 123. H. 2. 2009 S. S100-S100